Latest Breaking News On - Alto neuroscience inc - Page 1 : comparemela.com

Alto Neuroscience (NYSE:ANRO) Stock Rating Reaffirmed by William Blair

Alto Neuroscience (NYSE:ANRO – Get Free Report)‘s stock had its “outperform” rating reiterated by investment analysts at William Blair in a research report issued on Wednesday, RTT News reports. Several other research firms also recently weighed in on ANRO. Robert W. Baird started coverage on shares of Alto Neuroscience in a research report on Tuesday, […]

United statesNicholas conrad smithRobertw bairdWilliam blairStifel nicolausAlto neuroscience company profileAlto neuroscience incJennison associatesJefferies financial groupArtal groupInvestment company incAlto neuroscienceGet free reportFinancial groupConrad smithAlto neuroscience daily

Alto Neuroscience to Present at the Jefferies Global Healthcare Conference

Alto Neuroscience, Inc. today announced that Company management will participate in the Jefferies Global Healthcare Conference, taking place June 5-6, 2024, in New York. Amit Etkin, M.D., Ph.D.,.

New yorkUnited statesAmit etkinAlto neuroscience incAlto neuroscienceJefferies global healthcare conferencePrecision psychiatry platform

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJohn sonnenbergCherise chin fattAdam savitzSamanthav goncalvesNicholasj cooperPeter emmelAdamj savitzGuhan sundarMichael avissarDaniel mathalonGriffin hallBarbara echevarriaMark oplerFaizan badami

MEDRx : Collaboration Partner, Alto Neuroscience, Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia

News Release Dated April 24, 2024 MedRx Co., Ltd. Yonehiro Matsumura, CEO Stock code: 4586, TSE Growth .

Yonehiro matsumuraMedrx co ltdManagement departmentInhibitor in developmentMedrx companyAlto neuroscience incMedrx company limitedNews release dated aprilCollaboration partnerAlto neuroscienceAnnounces positive phaseCompany limitedManagement departmente mail

Alto Neuroscience (ANRO) Reports Positive Phase 1 Results for ALTO-101

Alto Neuroscience (ANRO) Reports Positive Phase 1 Results for ALTO-101
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amit etkinAlto neuroscience incAlto neuroscience